Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LYL845 |
Trade Name | |
Synonyms | LYL-845|LYL 845 |
Drug Descriptions |
LYL845 are polyclonal autologous tumor infiltrating lymphocytes, which potentially result in increased cytokine release and enhanced antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LYL845 | LYL845 | 0 | 1 |